Who is IMHOTEF PHARMACEUTICALS PRIVATE LIMITED?
IMHOTEF PHARMACEUTICALS PRIVATE LIMITED is a Chennai-based pharmaceutical company specializing in the retail sale of pharmaceutical and medical goods, cosmetics, and toilet articles.
Established on December 13, 2014, the company is classified as a non-government private entity and operates as a Company Limited by Shares.
With nearly a decade of experience, IMHOTEF PHARMACEUTICALS has built a strong presence in the Indian pharmaceutical sector, offering a range of healthcare products aimed at improving quality of life. The company is registered under the Registrar of Companies (ROC), Chennai, and remains active in the market with steady financial growth.
FASGO is an advanced pharmaceutical product developed by IMHOTEF PHARMACEUTICALS PRIVATE LIMITED, a Chennai-based company known for its expertise in producing high-quality medical and healthcare solutions.
As part of its growing portfolio, IMHOTEF PHARMACEUTICALS has introduced FASGO to address pain management and inflammation relief with a scientifically formulated composition that ensures fast and effective results.
With nearly a decade of experience in pharmaceutical retail and product development, the company aims to bridge the gap between affordability and quality. FASGO is a result of extensive research and development, providing consumers with a reliable and effective pain relief solution.
Who are the Directors of IMHOTEF PHARMACEUTICALS?
IMHOTEF PHARMACEUTICALS is spearheaded by two directors who bring extensive experience and expertise in the pharmaceutical industry:
- Raja G Gajendran
- Rajaa Vimala
Together, they have played a pivotal role in the company’s growth, innovation, and expansion into new markets.
What Makes FASGO a Unique Pharmaceutical Product?
FASGO has been designed to offer fast-acting and long-lasting relief for individuals experiencing muscle pain, joint stiffness, and inflammation-related discomfort. It has been formulated using scientifically backed ingredients to ensure optimal therapeutic effectiveness while minimizing potential side effects.
Key Features of FASGO
- Fast-acting formula that provides quick relief from pain and inflammation.
- Scientifically developed composition ensures effectiveness with minimal side effects.
- Designed for various pain types, including muscle pain, arthritis, and joint discomfort.
- Tested for safety and compliance, meeting regulatory pharmaceutical standards.
- Available for retail distribution through pharmacies and authorized sellers.
The product is aimed at improving the quality of life for patients suffering from acute and chronic pain conditions. Due to its strong efficacy and positive consumer response, FASGO has gained interest from investors and pharmaceutical distributors across India.
How Was FASGO Featured on the Startup Singam Show?
IMHOTEF PHARMACEUTICALS pitched FASGO on the Startup Singam Show on February 9, 2025, where they sought an investment of ₹1.25 crore with a valuation of ₹12.5 crore. This was a strategic move by the company to secure funding for expanding the production and marketing of FASGO, ensuring wider accessibility and availability in the Indian market.
Investment Offers for FASGO
During the show, the company received several investment offers from notable investors, each expressing strong interest in the potential growth of FASGO.
| Investor Name | Investment Offered (INR) | Purpose / Valuation |
| Native Lead | ₹70 Lakhs | ₹7.5 Crore |
| UAE Tamil Angels | ₹15 Lakhs | Technology & Website Development |
| JITO JIFF | ₹10 Lakhs | Not disclosed |
| Angel Investors | ₹10 Lakhs | Not disclosed |
Final Deal for FASGO
Following negotiations and deliberations, IMHOTEF PHARMACEUTICALS successfully closed an investment deal worth ₹1.05 crore at a valuation of ₹7.5 crore.
The secured investment will be utilized for:
- Scaling up the production of FASGO to meet increasing demand.
- Strengthening marketing and distribution strategies to enhance reach.
- Investing in research and development to improve product formulations.
- Enhancing technological infrastructure for better operational efficiency.
Where is IMHOTEF PHARMACEUTICALS Located?
IMHOTEF PHARMACEUTICALS operates from its headquarters in Chennai, Tamil Nadu, which serves as the central hub for its research, manufacturing, and distribution.
Company Address:
96 Dr, Moorthy Nagar Main Rd, Satyavathi Nagar, Padi, Chennai,
Tamil Nadu 600050
Contact Information:
- Email: info@imhotef.com
- Phone Number: 04426541768, 94440 85433
For further inquiries regarding FASGO’s availability, distribution partnerships, or bulk orders, interested parties are encouraged to contact the company via email or direct call.
How Can Consumers Purchase FASGO?
FASGO is available for purchase through:
- Retail pharmacy outlets across various regions.
- Authorized distributors and wholesalers handling pharmaceutical products.
- Direct inquiries and bulk orders via imhotef.com.
The company is actively working towards expanding its online and offline distribution channels, ensuring that FASGO reaches a wider consumer base.
What is the Future of FASGO in the Pharmaceutical Market?
With the recent investment boost and growing market demand, FASGO is set to expand its presence in the healthcare sector. IMHOTEF PHARMACEUTICALS aims to:
- Introduce advanced formulations with improved efficacy.
- Strengthen brand awareness through targeted marketing campaigns.
- Expand its distribution network to reach more customers across India.
- Collaborate with medical professionals to enhance product credibility.
The pharmaceutical industry is highly competitive, but with a scientifically backed product like FASGO, IMHOTEF PHARMACEUTICALS is well-positioned to become a key player in the pain relief segment.
